Catalyst Wire Dossier Catalyst Wire Dossier

Ondansetron (oral)

ondansetron
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ondansetron (oral), covering 2021-05-17 to 2021-05-17. Get the full timeline:

Most recent: Clinical Trial Update: Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation [Phase 3]

See pricing